Screening
56
16
18
24
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 56 trials
100.0%
+13.5% vs benchmark
2%
1 trials in Phase 3/4
17%
4 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (56)
Screening Volunteers for Clinical Trials
Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal
Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
Prevention and Early Identification for High Risk Youth in School-based Clinics
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns
Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
Prediabetes in End Stage Renal Disease on Dialysis
AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma
SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population
Universal Screening Program for Cytomegalovirus Infection in the First Trimester of Pregnancy (CITEMB Study)
UK Islet Autoantibody Registry
Artificial Intelligence in Breast Cancer Screening Programs
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
Smartwatch-Based AI Model for OSA Prediction (SWOSA)
A Patient Portal and PROMs to Improve Health Problem Detection and Retention in HIV Care: The DRHIVe Study
Improving Hepatocellular Carcinoma Screening
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas